Please login to the form below

Not currently logged in
Email:
Password:

Patheon hires Covance's Michael Lehmann for global pharma role

He joins the contract development and manufacturing company as president of global pharmaceutical development services

Michael Lehmann has left contract research organisation Covance to join Patheon as president of global pharmaceutical development services.

Patheon, which provides both contract development and manufacturing services to pharma companies, said that Lehmann's appointment will help drive the company's growth as it continues to transform its business amid varying marketing conditions.

This includes the company's recent acquisition of speciality pharma firm Banner Pharmacaps for $255m.

"I am pleased to be welcoming Mike and getting him quickly integrated with Patheon's leadership team," stated James Mullen, Patheon's CEO.

"He is a highly accomplished senior executive with a proven track record in the healthcare, life sciences and drug development sectors.”

Lehmann's most recent role was corporate senior VP and general manager of the global early development business of the contract research organisation (CRO) Covance.

During his time in this role, he helped Covance secure deals with both Lilly and Sanofi.

Prior to joining Covance, Lehmann spent 17 years at GE Healthcare in several senior roles, including general manager of multivendor services.

2nd November 2012

From: Research, Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...
Practical advice for Early Scientific Advice (ESA) in HTA submissions
A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence...